1 1

Farletuzumab ecteribulin [CAS 2407465-18-1]

Farletuzumab ecteribulin [CAS 2407465-18-1]

Size

QM-0200451-01

£1,581.60 GBP
Sale Sold out

Request quote or documents

View full details

Product Details

  • Description

    Farletuzumab ecteribulin (MORAb-202) is an antibody-drug conjugate (ADC), consisting of the humanized anti-human folate receptor alpha (FRA) antibody Farletuzumab conjugated via reduced interchain disulfide bonds to Mal-PEG2-Val-Cit-PAB-eribulin. Farletuzumab ecteribulin has a agent-to-antibody ratio of 4.0. Farletuzumab ecteribulin is highly cytotoxic to FRA-positive cells in vitro. Farletuzumab ecteribulin has potent antitumor activity.

  • CAS Number

    [2407465-18-1]

  • Smiles

    [Farletuzumabecteribulin]

  • Target

    Antibody-Drug Conjugates (ADCs)

  • Purity

    99.4

  • Solubility

    H2O

  • Storage Conditions

    -80°C, protect from light

  • Shipping Conditions

    Dry Ice
Learn more
Variant Variant total Quantity Price Variant total
1 mgQM-0200451-01
1 mgQM-0200451-01
£1,116.00
£1,581.60/ea
 £0.00
£1,116.00
£1,581.60/ea
 £0.00
5 mgQM-0200451-02
5 mgQM-0200451-02
£3,347.10
£4,593.59/ea
 £0.00
£3,347.10
£4,593.59/ea
 £0.00
10 mgQM-0200451-03
10 mgQM-0200451-03
£5,318.10
£7,254.44/ea
 £0.00
£5,318.10
£7,254.44/ea
 £0.00
View cart
0

Total items

£0.00

Product subtotal

Taxes, discounts and shipping calculated at checkout.
View cart

Related Products

Other industry favorites

Farletuzumab ecteribulin [CAS 2407465-18-1]

Farletuzumab ecteribulin is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.